Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Subjects will be asked to participate in a four day research study of the immune system
effects and safety of short-term acute dosing of Cold-fX.
The purpose of the study is to determine the effects of acute dosing of Cold-fX for 3 days on
the immune system compared to a placebo (dummy pill). Safety of the acute dosing will be
determined through various blood tests carried out during the study.